SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-016422
Filing Date
2020-07-01
Accepted
2020-07-01 09:05:08
Documents
8
Period of Report
2020-07-01

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea123632-6k_therapixbio.htm 6-K 21749
2 PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON JUNE 29, 2020, TITLED "THER ea123632ex99-1_therapix.htm EX-99.1 8188
3 PRESS RELEASE ISSUED BY THERAPIX BIOSCIENCES LTD. ON JULY 1, 2020, TITLED "THERA ea123632ex99-2_therapix.htm EX-99.2 5943
4 FORM OF SECURITIES PURCHASE AGREEMENT ea123632ex99-3_therapix.htm EX-99.3 235318
5 FORM OF WARRANT ea123632ex99-4_therapix.htm EX-99.4 100708
6 FORM OF REGISTRATION RIGHTS AGREEMENT ea123632ex99-6_therapix.htm EX-99.6 160539
7 GRAPHIC ex99-1_01.jpg GRAPHIC 28819
8 GRAPHIC ex99-2_01.jpg GRAPHIC 28113
  Complete submission text file 0001213900-20-016422.txt   612197
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 201004237
SIC: 2834 Pharmaceutical Preparations